Discrepancies between clients and therapists in their perceptions of the severity of the client's presenting problem were tested for their utility in predicting both premature and mutual termination. Eight problem types were examined, and analyses were conducted within a survival analysis framework. Across the majority of problem types, results indicated that greater discrepancies between clients and therapists lowered the odds of mutual termination; however, greater discrepancies did not in turn increase the odds of premature termination. Interaction tests of client-therapist discrepancy with a variable that changes over time, accruing number of sessions, offer some qualifications. In particular, in the case of two problem types--depression and family-of-origin--when large discrepancies occurred, the likelihood of premature termination maintained at an equal rate throughout treatment, whereas when discrepancies were moderate or absent, the likelihood of premature termination diminished. Implications for clinicians and researchers point to enhancement of the therapeutic alliance as a means of reducing the probability of premature termination and increasing the probability of mutual termination. (PsycINFO Database Record (c) 2010 APA, all rights reserved).

Download full-text PDF

Source
http://dx.doi.org/10.1037/0033-3204.44.2.193DOI Listing

Publication Analysis

Top Keywords

premature termination
16
mutual termination
12
presenting problem
8
discrepancies clients
8
clients therapists
8
problem types
8
greater discrepancies
8
likelihood premature
8
termination
7
problem
5

Similar Publications

Background: Rifampin therapy is indicated for the treatment of staphylococcal periprosthetic joint infection (PJI) in patients who have undergone debridement, antibiotics, and implant retention (DAIR) or one-stage revision as per the Infectious Diseases Society of America (IDSA) guideline. Given the well-established effectiveness of rifampin as adjunctive therapy in staphylococcal PJI, it is crucial to evaluate its utilization in practice and identify factors that contribute to its underuse or incomplete administration, as these deviations may undermine treatment efficacy and patient outcomes.

Questions/purposes: Among patients who met clear indications for rifampin use having undergone DAIR or one-stage revision for staphylococcal PJI, (1) what proportion of patients did not receive it? (2) What proportion of patients started it but did not complete the planned course? (3) Where documented in the medical record, what were the common reasons for not using it or prematurely discontinuing it, and in what percentage of the patients' charts was no reason given? (4) What proportion of patients were taking a medication that put them at risk for a drug-drug interaction (DDI)?

Methods: Using an institutional database, patients who underwent DAIR or revision arthroplasty for PJI from January 2013 to April 2023 were identified (n = 935).

View Article and Find Full Text PDF

Targeting Kv7 Potassium Channels for Epilepsy.

CNS Drugs

January 2025

Division of Pharmacology, Department of Neuroscience, University of Naples "Federico II", Naples, Italy.

Voltage-gated Kv7 potassium channels, particularly Kv7.2 and Kv.7.

View Article and Find Full Text PDF

Personalized antisense oligonucleotides (ASOs) have achieved positive results in the treatment of rare genetic disease. As clinical sequencing technologies continue to advance, the ability to identify patients with rare disease harbouring pathogenic genetic variants amenable to this therapeutic strategy will probably improve. Here we describe a scalable platform for generating patient-derived cellular models and demonstrate that these personalized models can be used for preclinical evaluation of patient-specific ASOs.

View Article and Find Full Text PDF

Introduction: Early pregnancy care involves the screening and identification of women with risk factors for adverse pregnancy outcomes, including stillbirth or preterm birth, to tailor pregnancy care and interventions accordingly. Most stillbirths and approximately two-thirds of preterm births, however, occur in the absence of evident risk factors. The majority of stillbirths occur in the preterm period, yet there are few interventions targeting this period, and progress to reduce stillbirth rates remains slow.

View Article and Find Full Text PDF

Objective: We aim to assess which variables are associated with recruitment failure of obstetrical and gynaecological randomised controlled trials (RCTs), leading to an extension of the study period.

Design: Nationwide study.

Setting: A cohort of RCTs supported by the trial centre of the Dutch Consortium of Obstetrics and Gynaecology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!